Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Income from Non-Controlling Interests of $200000.0 in Q1 2026, up 113.33% quarter-over-quarter from -$1.5 million in Q4 2025, and down 66.67% on a YoY basis from $600000.0 in Q1 2025.
Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income from Non-Controlling Interests history runs 16 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 66.67% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at -$400000.0 (down 122.22% YoY), while the FY2025 annual figure was -$100000.0, down 106.67% from the prior year.
- Income from Non-Controlling Interests was $200000.0 for Q1 2026 at Zimmer Biomet Holdings, up from -$1.5 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $700000.0 in Q4 2024 to a low of -$1.5 million in Q4 2025.
- Historically, Income from Non-Controlling Interests has averaged $229411.8 across 5 years, with a median of $300000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests surged 200.0% in 2022, then tumbled 314.29% in 2025.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $300000.0 in 2022, then jumped by 66.67% to $500000.0 in 2023, then surged by 40.0% to $700000.0 in 2024, then slumped by 314.29% to -$1.5 million in 2025, then surged by 113.33% to $200000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $200000.0 (Q1 2026), -$1.5 million (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 600,000.00 |